AP
RTO icon

Arlington Partners’s Rentokil RTO Stock Holding History

Arlington Partners’s Portfolio RTO Stock Details RTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-7,698
Closed -$220K – 49
2026
Q2 		$220K Hold
7,698
– – 0.4% 56
2026
Q1 		$242K Buy
+7,698
New +$243K 0.48% 19
2025
Q4 		– Sell
-200,101
Closed -$5.05M – 46
2025
Q3 		$5.05M Buy
200,101
+131,826
+193% +$3.21M 1.75% 22
2025
Q2 		$1.64M Buy
+68,275
New +$1.58M 0.6% 63

Other funds holding RTO

Nichols & Pratt Advisers
Nichols & Pratt Advisers Boston, Massachusetts $1.68B AUM 20.22% 1-Year Est. Return
Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return
Patriot Financial Group Insurance Agency
Patriot Financial Group Insurance Agency Westborough, Massachusetts $1.05B AUM 21.28% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Diversified Management
Diversified Management Milwaukee, Wisconsin $573M AUM 24.64% 1-Year Est. Return
Aaron Wealth Advisors
Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return
VisionPoint Advisory Group
VisionPoint Advisory Group Dallas, Texas $636M AUM 21.4% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
FNY Investment Advisers
FNY Investment Advisers New York $402M AUM 85.34% 1-Year Est. Return
CIA
Cape Investment Advisory Mcdonough, Georgia $388M AUM 17.15% 1-Year Est. Return

Arlington Partners's RTO Position: Q3 2026 in Review

Arlington Partners sold out of Rentokil (RTO) in Q3 2026, closing a stake of 7,698 shares — an estimated $220K sold.

Arlington Partners first reported a position in RTO in Q2 2025 and held it in 4 quarters. The position peaked at $5.05M in Q3 2025. 31 funds tracked by Wall St. Rank hold RTO as of Q3 2026.

  • Arlington Partners reported no remaining Rentokil position as of Q3 2026 after selling out during the quarter.
  • Arlington Partners sold 7,698 Rentokil shares in Q3 2026, an estimated $220K.
  • Arlington Partners first reported a position in Rentokil in Q2 2025 and held it in 4 quarters.
  • Arlington Partners's Rentokil position peaked at $5.05M in Q3 2025.
  • 31 funds tracked by Wall St. Rank held Rentokil as of Q3 2026.

Based on Arlington Partners's 13F filing for Q3 2026, filed 20 Oct 2026.